+91 888 589 6523CONTACT US
0item(s)

You have no items in your shopping cart.

Product was successfully added to your shopping cart.

Apixaban- Drug Molecule Intelligence (100 Countries)

Details

Apixaban- Drug Molecule Intelligence report provides comprehensive data on product information, application areas, manufacturing methods, formulation details, regulatory approval, data exclusivity, generic launch constrained date, market trends, manufacturers and suppliers details. The report also provides key patents, extension, and data exclusivity expiry for 66 countries, regulatory issues and key players. The report covers patent information and data exclusivity covering 66 countries, including extension details (SPC and national law) for 30 European countries, Australia, Canada, Israel, Japan and the USA. The report covers the Market Assessment of the Apixaban covering the historical global sales and also provides the Apixaban sales estimation during the forecasted period (2017-2021). Country Coverage: Albania Argentina Australia Austria Belgium Bosnia & Herzegovina Brazil Bulgaria Canada Chile China Colombia Croatia Cyprus Czech Republic Denmark Estonia Finland Former Yugoslav Republic of Macedonia France Germany Great Britain Greece Hong Kong Hungary Iceland India Indonesia Ireland Israel Italy Japan Latvia Liechtenstein Lithuania Luxembourg Macedonia Malaysia Malta Mexico Monaco Montenegro The Netherlands New Zealand Norway Philippines Poland Portugal Romania Russia San Marino Serbia Singapore Slovakia Slovenia South Africa South Korea Spain Sweden Switzerland Thailand Turkey Ukraine Uruguay USA Viet Nam

Details

Details

Product Tags

Use spaces to separate tags. Use single quotes (') for phrases.

  1. Be the first to review this product

Write Your Own Review

Only registered users can write reviews. Please, log in or register

$2,000.00

* Required Fields

$2,000.00